The Cohort Study of Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03377972

Enrollment

500

Registered

2017-12-19

Start date

2018-01-01

Completion date

2018-12-01

Last updated

2017-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection

Brief summary

Endoscopic Submucosal Dissection (ESD) is currently the main method of treatment of early esophageal cancer and precancerous lesions. Therefore, the investigators are looking forward to conduct a cohort study on early esophageal cancer patients undergoing endoscopic treatment collected from Zhongshan Hospital, Fudan University, comparing the WHO standard with Japanese standard of endoscopic therapy diagnosis. In addition，the investigators will collect patients' detailed informations and analyze the risk factors for metastasis and recurrence of early esophageal cancer.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

15 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Older than 15-year-old 2. Undergoing endoscopic Submucosal Dissection (ESD) in ZhongShan Hospital

Exclusion criteria

Preoperative patients with recurrence and Lost to follow-up of patients within 1 year

Design outcomes

Primary

Measure	Time frame	Description
Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.	December 1st,2017-December 1st,2018	Comparison WHO diagnosis standard with JAPAN in Early Esophageal Cancer patients by accessing pathological section.

Outcome results